US 7538125
Pharmaceutical composition
granted A61KA61K31/135A61K31/19
Quick answer
US patent 7538125 (Pharmaceutical composition) held by Takeda Pharmaceutical Company Limited expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/135, A61K31/19, A61K31/415, A61K31/42